Combiotech Research and Production Company was founded in 1992 to put into practice the scientific medical developments. Combiotech is a modern hi-tech enterprise manufacturing high efficient safe vaccines to be used for mass inoculation for both children and adults.
The company was the first in Russia to work out and manufacture recombinant yeast hepatitis B vaccine through complete technology cycle using domestic raw products and technology. The properties of this vaccine meet the WHO standards. Vaccine is highly competitive when compared to other global analogues and even outstrips them in some parameters.
Most of the manufactured products are supplied within the framework of implementation of the state order for inoculation of the newborn babies.
Being the leader in development and introduction of new vaccines, Combiotech has already developed, introduced and licensed the first Russian combined vaccine Bubo-М inoculating against diphtheria, tetanus and hepatitis B at once, and Bubo-Kok - combined vaccine consisting of diphteria and tetanus toxoids and pertussis vaccine and Hepatitis B vaccine.
The company has recently revealed its new development – second-to-none preservative-free hepatitis B vaccine, free of merthiolate or any other preservative.
The company also produces surface hepatitis B antigen (HBsAg), which contains various stereotype determinants and is used for diagnostic purpose.
At the moment there are high efficient Russian immunobiological medical preparations able to provide immunological prophylaxis of viral hepatitis B. The company production facilities are sufficient for provision of the scheduled immunization in Russia and meeting import requirements.